Search

Grayson W Stowell

from Holly Springs, NC
Age ~52
Get Report
Also known as:
Grayson Walker Stowell, Grayson Janice Stowell, Stowell Walker Grayson
Phone and address:
6205 O C Hester Rd, Holly Springs, NC 27540
Related to:
Walker Stowell Grayson, 50
Connected to:
Austin M Stowell, 39Bradford P Stowell, 71Brendan J Stowell, 57Byron Stowell, 53Cassandra A Stowell, 34Christine R Stowell, 51Darren Stowell, 63Denise C Stowell, 68Devin C Stowell, 32Erik D Stowell, 63

Grayson Stowell Phones & Addresses

  • 6205 O C Hester Rd, Holly Springs, NC 27540
    • s
  • 213 Lost Tree Ln, Cary, NC 27513
  • Morrisville, NC
  • Schoharie, NY
  • Wilmington, NC
  • 14 Pilgrims Way, Gaylordsville, CT 06755 (860) 354-1668
  • Canajoharie, NY
  • 213 Lost Tree Ln, Cary, NC 27513 (860) 354-1668

Work

Company: Catalent pharma solutions Jun 2012 Address: Raleigh-Durham, North Carolina Area Position: Senior project manager

Education

School / High School: East Carolina University - College of Business 2011 to 2014 Specialities: MBA

Skills

Drug Development • Pharmaceutical Industry • Gmp • Glp • Technology Transfer • Biopharmaceuticals • Fda • Biotechnology • 21 Cfr Part 11 • Validation • V&V • Cro • Sop • Analytical Chemistry • Pharmaceutics • Chemistry • Hplc • Clinical Development • Regulatory Affairs • Change Control • Formulation • Capa • Lims • Cross Functional Team Leadership • R&D • Chromatography • Regulatory Submissions • Gxp • Quality System • Drug Discovery • Life Sciences • Lifesciences • Computer System Validation • Clinical Trials

Industries

Pharmaceuticals

Resumes

Resumes

Grayson Stowell Photo 1

Program Manager, Global Health Technologies

View page
Location:
6205 O C Hester Rd, Holly Springs, NC 27540
Industry:
Pharmaceuticals
Work:
Catalent Pharma Solutions - Raleigh-Durham, North Carolina Area since Jun 2012
Senior Project Manager
Catalent Pharma Solutions Apr 2011 - Jun 2012
Group Leader
MannKind Corporation Apr 2005 - Apr 2011
Associate Director, Formulations Development
AAIPharma Services Corp. Dec 1996 - Mar 2005
Senior Scientist, Discovery Sciences Group
Oneida Research Services Jun 1994 - Nov 1996
Supervisor
Education:
East Carolina University - College of Business 2011 - 2014
University of New Haven 2010 - 2011
University of North Carolina at Wilmington 1998 - 2001
MS, Chemistry State University of New York College at Oneonta 1991 - 1994
BA, Chemistry Utica College 1990 - 1991
Skills:
Drug Development
Pharmaceutical Industry
Gmp
Glp
Technology Transfer
Biopharmaceuticals
Fda
Biotechnology
21 Cfr Part 11
Validation
V&V
Cro
Sop
Analytical Chemistry
Pharmaceutics
Chemistry
Hplc
Clinical Development
Regulatory Affairs
Change Control
Formulation
Capa
Lims
Cross Functional Team Leadership
R&D
Chromatography
Regulatory Submissions
Gxp
Quality System
Drug Discovery
Life Sciences
Lifesciences
Computer System Validation
Clinical Trials

Publications

Us Patents

Alkoxy Substituted Benzimidazole Compounds, Pharmaceutical Preparations Containing The Same, And Methods Of Using The Same

View page
US Patent:
6369087, Apr 9, 2002
Filed:
Aug 24, 2000
Appl. No.:
09/645145
Inventors:
Robert R. Whittle - Wilmington NC, 28403
Frederick D. Sancilio - Wilmington NC, 28405
Grayson Walker Stowell - Wilmington NC, 28405
Douglas John Jenkins - Wilmington NC, 28411-8323
Linda B. Whittall - Wilmington NC, 28411
International Classification:
A61K 3144
US Classification:
514338
Abstract:
Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Polymorphic Forms Of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone

View page
US Patent:
6388080, May 14, 2002
Filed:
Jun 29, 2001
Appl. No.:
09/896448
Inventors:
Grayson Walker Stowell - Wilmington NC, 28405
Robert R. Whittle - Wilmington NC, 28403
International Classification:
C07D40112
US Classification:
546155
Abstract:
Polymorphs Form B, Form C, and amorphous of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, commonly known as cilostazol, have been identified. These polymorphs may be formed in pure form, in combination with each other, in combination with other polymorphs of cilostazol, or together with other pharmaceutical agents. Processes for preparing these polymorphs, and combinations of these polymorphs, as well as methods of use and unit dosages of these polymorphic forms, and their combinations, are described.

Alkoxy Substituted Benzimidazole Compounds, Pharmaceutical Preparations Containing The Same, And Methods Of Using The Same

View page
US Patent:
6444689, Sep 3, 2002
Filed:
Jan 25, 2002
Appl. No.:
10/057659
Inventors:
Robert R. Whittle - Wilmington NC, 28403
Frederick D. Sancilio - Wilmington NC, 28405
Grayson Walker Stowell - Wilmington NC, 28405
Douglas John Jenkins - Wilmington NC, 28411-8323
Linda B. Whittall - Wilmington NC, 28411
International Classification:
A61K 3144
US Classification:
514338
Abstract:
Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Form A Of Fluoxetine Hydrochloride

View page
US Patent:
6492556, Dec 10, 2002
Filed:
Nov 5, 2001
Appl. No.:
09/991839
Inventors:
Grayson Walker Stowell - Wilmington NC, 28405
Robert R. Whittle - Wilmington NC, 28403
International Classification:
C07C21300
US Classification:
564347
Abstract:
The present invention relates to novel polymorphic Form A of fluoxetine hydrochloride.

Polymorphic Forms Of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone

View page
US Patent:
6531603, Mar 11, 2003
Filed:
Jun 29, 2001
Appl. No.:
09/896184
Inventors:
Grayson Walker Stowell - Wilmington NC, 28405
Robert R. Whittle - Wilmington NC, 28403
International Classification:
C07D21536
US Classification:
546158, 514312
Abstract:
Polymorphs Form B, Form C, and amorphous of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, commonly known as cilostazol, have been identified. These polymorphs may be formed in pure form, in combination with each other, in combination with other polymorphs of cilostazol, or together with other pharmaceutical agents. Processes for preparing these polymorphs, and combinations of these polymorphs, as well as methods of use and unit dosages of these polymorphic forms, and their combinations, are described.

Polymorphic Forms Of 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone

View page
US Patent:
6573382, Jun 3, 2003
Filed:
Jun 29, 2001
Appl. No.:
09/896067
Inventors:
Grayson Walker Stowell - Wilmington NC, 28405
Robert R. Whittle - Wilmington NC, 28403
International Classification:
C07D21560
US Classification:
546156, 546153, 514312
Abstract:
Polymorphs Form B, Form C, and amorphous of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, commonly known as cilostazol, have been identified. These polymorphs may be formed in pure form, in combination with each other, in combination with other polymorphs of cilostazol, or together with other pharmaceutical agents. Processes for preparing these polymorphs, and combinations of these polymorphs, as well as methods of use and unit dosages of these polymorphic forms, and their combinations, are described.

Polymorphic Forms Of 6-[4-(1-Cyclohexyl-1H-Tetraol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone

View page
US Patent:
6596871, Jul 22, 2003
Filed:
Jun 29, 2001
Appl. No.:
09/896800
Inventors:
Grayson Walker Stowell - Wilmington NC, 28405
Robert R. Whittle - Wilmington NC, 28405
International Classification:
A61K 3147
US Classification:
546158, 514312
Abstract:
Polymorphs Form B, Form C, and amorphous of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, commonly known as cilostazol, have been identified. These polymorphs may be formed in pure form, in combination with each other, in combination with other polymorphs of cilostazol, or together with other pharmaceutical agents. Processes for preparing these polymorphs, and combinations of these polymorphs, as well as methods of use and unit dosages of these polymorphic forms, and their combinations, are described.

Process For Purifying 6-Methoxy Omeprazole

View page
US Patent:
6608091, Aug 19, 2003
Filed:
Apr 20, 2001
Appl. No.:
09/839449
Inventors:
Linda B. Whittall - Wilmington NC, 28411
Grayson Walker Stowell - Wilmington NC, 28405
Robert R. Whittle - Wilmington NC, 28403
International Classification:
A61K 3144
US Classification:
514338, 5462737
Abstract:
The present invention provides processes for purifying 6-methoxy omeprazole, products using such processes, pharmaceutical formulations using such products, and methods of using such products for gastric acid inhibition.
Control profile
Grayson W Stowell from Holly Springs, NC, age ~52 Get Report